Aesthetic Medical International Holdings Group (PAIYY) AI Stock Analysis

• Market Cap: $6.57M
• Dividend Yield: N/A
• Average Volume (3M): 576.00
• Price to Earnings (P/E): ―
• Beta (1Y): -0.63
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: US
• Employees: 1,286
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Equipment & Services
• EPS (TTM): N/A
• Shares Outstanding: 48,687,584
• 10 Day Avg. Volume: 50
• 30 Day Avg. Volume: 576
• PEG Ratio: 0.04
• Price to Book (P/B): 1.17
• Price to Sales (P/S): 0.05
• P/FCF Ratio: 0.73
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 45 Neutral
• Price Target: $0.13 ▼(-54.83% Downside)

The score is primarily weighed down by financial risk: despite improving operating losses and stronger free cash flow, the company remains unprofitable and highly leveraged. Technicals add modest pressure as the stock trades below key longer-term averages with negative MACD, while valuation cannot be meaningfully assessed due to missing P/E and dividend data.

Positive Factors

Revenue and EBIT improvement

Double-digit revenue growth alongside a material narrowing of EBIT losses indicates strengthening demand and improving operational leverage. Sustained top-line expansion and reduced operating losses provide a clearer pathway to recurring profitability over the next several quarters if trends continue.

Cash generation improving

Conversion of earnings into cash has improved, with free cash flow turning positive and operating cash flow exceeding net income. Stronger cash generation enhances liquidity and reduces reliance on external funding, supporting investment in clinics and R&D over the medium term.

Balance sheet improvements

Noted gains in equity and better asset management signal strengthening financial discipline. Gradual repair of the balance sheet improves solvency metrics and investor confidence, which supports expansion or partnership opportunities over the coming quarters if management sustains these actions.

Negative Factors

High leverage / low equity ratio

A very low equity ratio and heavy debt reliance constrain financial flexibility and increase refinancing and interest-rate risks. High leverage magnifies downside from revenue shocks and limits the company’s ability to fund capex or strategic initiatives without raising costly capital.

Ongoing negative profitability

Despite operating improvements, net profitability is still negative, indicating the company has not yet reached sustainable earnings. Persistent net losses can erode equity, necessitate continual external funding, and delay returns to investors until structural profitability is achieved.

Need for continued cost control

The path to durable profitability depends on sustained cost discipline; one-off improvements in EBIT are insufficient without ongoing margin control. Failure to consistently manage operating costs could reverse progress and extend the timeline to profitability and free-cash-flow sustainability.

Aesthetic Medical International Holdings Group Business Overview & Revenue Model

Company Description

Aesthetic Medical International Holdings Group (PAIYY) is a leading provider of aesthetic medical services and products in China. The company operates a network of outpatient clinics that offer a wide range of non-surgical aesthetic procedures, including skin rejuvenation, body contouring, and cosmetic injections. PAIYY also engages in the research, development, and distribution of aesthetic medical devices and products, catering to the growing demand for cosmetic enhancements in the region.

How the Company Makes Money

The company generates revenue primarily through its aesthetic medical services offered at its clinics. This includes fees from various non-invasive procedures and treatments that clients seek for cosmetic enhancements. Additionally, PAIYY earns income from the sale of aesthetic medical devices and products, which are either developed in-house or sourced from partnerships with other manufacturers. The company may also benefit from strategic alliances or collaborations with other healthcare providers, enhancing its service offerings and expanding its market reach. Through these diversified revenue streams, PAIYY capitalizes on the increasing consumer interest in aesthetic treatments, contributing significantly to its overall earnings.

Aesthetic Medical International Holdings Group Financial Statement Overview

Summary

Aesthetic Medical International Holdings Group is making strides towards improvement, with notable revenue growth and better cash flow management. Nevertheless, profitability remains elusive, and the balance sheet's leverage presents risks. Continued focus on reducing debt and enhancing profitability is essential for future stability.

Income Statement

The company has shown improvement in reducing its operating losses, with EBIT rising from -48.81 million to -4.04 million. Revenue growth is evident with a 10.7% increase from the previous year. However, the net profit margin remains negative, indicating ongoing challenges in achieving profitability. Continued focus on cost management is needed.

Balance Sheet

The company's financial stability is concerning, with a high debt-to-equity ratio due to significant liabilities overshadowing the small equity base. The equity ratio is low at 6.3%, indicating heavy reliance on debt financing. However, there have been improvements in stockholders' equity and asset management, which is a positive sign.

Cash Flow

The cash flow situation has improved, with a positive free cash flow growing significantly from the previous year. The operating cash flow is healthy and exceeds net income, indicating strong cash generation capabilities despite net losses. Continued improvement in free cash flow sustainability is crucial.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	755.67M	682.59M	670.09M	645.59M	901.57M
Gross Profit	337.79M	322.05M	355.59M	269.50M	544.78M
EBITDA	73.33M	25.31M	-11.05M	-554.95M	-123.90M
Net Income	-19.95M	-37.43M	-76.25M	-586.62M	-235.48M
Balance Sheet
Total Assets	486.22M	560.66M	546.37M	576.94M	1.04B
Cash, Cash Equivalents and Short-Term Investments	42.84M	62.34M	12.16M	39.29M	44.38M
Total Debt	179.30M	244.55M	393.10M	405.91M	460.79M
Total Liabilities	476.88M	527.03M	672.25M	763.36M	612.35M
Stockholders Equity	30.46M	48.89M	-113.66M	-156.67M	390.90M
Cash Flow
Free Cash Flow	48.88M	18.83M	-76.80M	17.65M	-46.01M
Operating Cash Flow	79.67M	74.29M	-75.13M	51.09M	-843.00K
Investing Cash Flow	-30.32M	-52.25M	3.11M	-11.53M	-127.37M
Financing Cash Flow	-68.55M	29.06M	45.55M	-45.23M	17.70M

Aesthetic Medical International Holdings Group Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.29
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PAIYY, the sentiment is Negative. The current price of 0.29 is above the 20-day moving average (MA) of 0.11, above the 50-day MA of 0.15, and above the 200-day MA of 0.19, indicating a bearish trend. The MACD of -0.01 indicates Negative momentum. The RSI at 45.68 is Neutral, neither overbought nor oversold. The STOCH value of 42.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for PAIYY.

Aesthetic Medical International Holdings Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
NCNA	46 Neutral	$13.73M	-0.02	-179.40%	―	―	94.52%
HSCS	46 Neutral	$10.07M	-0.44	-220.42%	―	-41.03%	35.71%
PAIYY	45 Neutral	$6.57M	―	-76.57%	―	―	―
TNMG	38 Underperform	$5.93M	-0.03	-164.27%	―	4.59%	-920.35%